| Not Yet Recruiting | Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdomin Postoperative Pain | Phase 1 | 2026-03-31 |
| Active Not Recruiting | A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Relea Type 2 Diabetes | Phase 3 | 2025-06-20 |
| Not Yet Recruiting | A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis Moderate to Severe Plaque Psoriasis | Phase 3 | 2025-06-01 |
| Not Yet Recruiting | Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients Severe Alopecia Areata | Phase 2 | 2025-05-26 |
| Recruiting | A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder Major Depressive Disorder (MDD) | Phase 3 | 2025-04-11 |
| Not Yet Recruiting | Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Pancreatic Cancer | Phase 3 | 2024-09-01 |
| Not Yet Recruiting | Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia Presbyopia | Phase 3 | 2024-06-30 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients Non-segmental Vitiligo | Phase 2 | 2024-05-27 |
| Not Yet Recruiting | A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy Painful Diabetic Neuropathy | Phase 3 | 2024-05-15 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011 Advanced Breast Cancer | Phase 2 | 2024-04-01 |
| Unknown | A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Comp Advanced Breast Cancer | Phase 3 | 2023-05-01 |
| Completed | An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque P Effects, Drug Side | Phase 2 | 2023-04-11 |
| Completed | A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus Invasive Candidiasis, Invasive Aspergillosis | Phase 3 | 2023-03-30 |
| Unknown | Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 | 2023-03-01 |
| Unknown | A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2022-12-01 |
| Completed | Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy Subjects Healthy Participants | Phase 1 | 2022-05-26 |
| Unknown | A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer Advanced Breast Cancer | Phase 1 | 2022-03-31 |
| Unknown | Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic | Phase 2 | 2021-10-01 |
| Terminated | Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma | Phase 2 | 2021-09-01 |
| Completed | A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD Invasive Mold Disease | Phase 3 | 2021-07-09 |
| Unknown | The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects Healthy Subjects | Phase 1 | 2021-05-31 |
| Completed | Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance Advanced Breast Cancer | Phase 1 | 2021-05-31 |
| Completed | Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC) Small Cell Lung Cancer (SCLC) | Phase 2 | 2021-03-01 |
| Unknown | Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer. Advanced Pancreatic Cancer | Phase 1 | 2020-07-07 |